3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Hodgkin Disease
10
Lymphoma
5
Neoplasms, Germ Cell and Embryonal
3
Seminoma
2
Vulvar Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hemangioma, Capillary
1
Endodermal Sinus Tumor
1
Desmoid Tumors
1
Carcinoma, Embryonal
1
Interventions
Varenicline
1
Tyrosine Kinase Inhibitors
1
Trastuzumab
1
Tobacco Use Cessation Devices
1
Registries
1
Patient Reported Outcome Measures
1
Nicotine Chewing Gum
1
Interviews as Topic
1
Cisplatin
1
Bupropion
1
Bleomycin
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Second Primary
×
Bleomycin
×
1 year
×
Clear all
NCT03199300
2025-12-11
InvestiCAT
University Medical Center Groningen
Active not recruiting
20 enrolled